Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

DMAC holding history

DiaMedica Therapeutics Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMAC overviewAll 13F holders of DMACFull Q4 2025 holdings

Shares (Q4 2025)
723,120
Value
$5.76M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of DMAC by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025723,120$5.76M<0.1%+58,545+8.8%AddedHolders
Q3 2025664,575$4.57M<0.1%−870,479−56.7%ReducedHolders
Q2 20251,535,054$5.99M<0.1%+183,587+13.6%AddedHolders
Q1 20251,351,467$5.12M<0.1%+109,360+8.8%AddedHolders
Q4 20241,242,107$6.74M<0.1%+193,078+18.4%AddedHolders
Q3 20241,049,029$4.40M<0.1%+31,627+3.1%AddedHolders
Q2 20241,017,402$3.00M<0.1%+3,880+0.4%AddedHolders
Q1 20241,013,522$2.81M<0.1%+211,351+26.3%AddedHolders
Q4 2023802,171$2.28M<0.1%+13,382+1.7%AddedHolders
Q3 2023788,789$2.04M<0.1%+5,800+0.7%AddedHolders
Q2 2023782,989$3.38M<0.1%00.0%UnchangedHolders
Q1 2023782,989$1.20M<0.1%00.0%UnchangedHolders
Q4 2022782,989$1.24M<0.1%+3490.0%AddedHolders
Q3 2022782,640$971.0K<0.1%00.0%UnchangedHolders
Q2 2022782,640$1.58M<0.1%00.0%UnchangedHolders
Q1 2022782,640$1.96M<0.1%−3,912−0.5%ReducedHolders
Q4 2021786,552$2.93M<0.1%−984−0.1%ReducedHolders
Q3 2021787,536$3.16M<0.1%+1,270+0.2%AddedHolders
Q2 2021786,266$3.50M<0.1%−60,047−7.1%ReducedHolders
Q1 2021846,313$7.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.